Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 34 min ago
PreprintCC BY-NC-NDbioRxiv

Population genomics of Candida albicans reveals genetic footprints that allow the prediction of antifungal resistance

2 more authors
  1. 1Universite Laval

Abstract

Rapid detection of drug resistance in fungi is becoming increasingly urgent. While multiple loci and mutations were linked to antifungal resistance in Candida albicans, the utility of whole genome sequencing in predicting resistance has not been tested thoroughly. We address this by integrating more than 1000 C. albicans genomes, with associated resistance phenotypes to six antifungals, a curated repository of resistance-causing mutations and variant effect predictors. We used Genome Wide Association Studies and Machine Learning approaches to associate genetic variants to resistance phenotypes. We found that well curated databases like FungAMR are able to accurately identify markers predictive antifungal resistance. Curated mutations were detected in 56 to 74% of isolates with reduced azole susceptibility and 57 to 90% of those with reduced echinocandin susceptibility, revealing incomplete coverage of resistance across both drug classes. Complementary variant- and gene-level association analyses recovered established resistance determinants and uncovered additional candidate loci, whereas copy-number changes provided limited independent explanatory power. Genomic prediction declined when genetic backgrounds were absent from training, and when leading predictive features differed among backgrounds. We also found that models trained on a curated list of mutations and variant effect predictors performed well when classifying drug-susceptible strains, but the drug-resistance trait was predicted with lower accuracy. These findings support the potential of genome-based resistance prediction while highlighting the need for broader population sampling, functional validation of candidate variants and expanded resistance catalogues to improve prediction across genetic backgrounds.

Related

  1. Global population genomics and pangenome of the clubroot pathogen link clonal expansion and effector diversification to resistance breakdown in canola
    M. A. Javed, F. Sylvestre, S. M. Velasco Cuervo +34
    bioRxivPreprintCC BY-NC-NDFull textGenetics & genomicsbioRxiv
  2. Comparative genomics of canonical antifungal dsRNA target genes across fungal plant pathogens: conserved siRNA-length windows define the scope for broad-spectrum spray-induced gene silencing
    M. Wasif, M. A. Khan, M. A. Azmat +2
    bioRxivPreprintCC BYFull textGenetics & genomicsbioRxiv
  3. Antifungal Resistance and Adhesin-Mediated Phenotypic Plasticity Among Genomically Diverse Candida auris Clinical Isolates
    T. Wang, T. Ma, C. Zhou +4
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  4. Species Distribution, Antifungal Susceptibility, and Machine Learning-Based Prediction of Optimal Therapies Against Candida Species
    P. Paik, R. tilak, P. Tiwari +3
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  5. Population Genomics of Almond ( Prunus dulcis ) Reveals Region‐Specific Selection and a Complex History of Domestication
    C. Lougmani, A. Mesnil, R. Fahmy +10
    Molecular EcologyPeer-reviewedLicence not statedFull textGenetics & genomicsHAL
BibTeX
@misc{jay2026population,
  title = {{Population genomics of Candida albicans reveals genetic footprints that allow the prediction of antifungal resistance}},
  author = {A. Jay and C. Bedard and A. Pageau and I. Gagnon-Arsenault and C. Bautista and J. V. Kus and L. McTaggart and T. Dingle and S. Shokoples and D. G. De Luca and A. Bharat and P. J. Dufresne and A. Fijarczyk and C. Landry},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.28.762049},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.28.762049v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Population genomics of Candida albicans reveals genetic footprints that allow the prediction of antifungal resistance
AU  - A. Jay
AU  - C. Bedard
AU  - A. Pageau
AU  - I. Gagnon-Arsenault
AU  - C. Bautista
AU  - J. V. Kus
AU  - L. McTaggart
AU  - T. Dingle
AU  - S. Shokoples
AU  - D. G. De Luca
AU  - A. Bharat
AU  - P. J. Dufresne
AU  - A. Fijarczyk
AU  - C. Landry
PY  - 2026
DA  - 2026/10/28
PB  - bioRxiv
DO  - 10.64898/2026.10.28.762049
UR  - https://www.biorxiv.org/content/10.64898/2026.10.28.762049v1
AB  - Rapid detection of drug resistance in fungi is becoming increasingly urgent. While multiple loci and mutations were linked to antifungal resistance in Candida albicans, the utility of whole genome sequencing in predicting resistance has not been tested thoroughly. We address this by integrating more than 1000 C. albicans genomes, with associated resistance phenotypes to six antifungals, a curated repository of resistance-causing mutations and variant effect predictors. We used Genome Wide Association Studies and Machine Learning approaches to associate genetic variants to resistance phenotypes. We found that well curated databases like FungAMR are able to accurately identify markers predictive antifungal resistance. Curated mutations were detected in 56 to 74% of isolates with reduced azole susceptibility and 57 to 90% of those with reduced echinocandin susceptibility, revealing incomplete coverage of resistance across both drug classes. Complementary variant- and gene-level association analyses recovered established resistance determinants and uncovered additional candidate loci, whereas copy-number changes provided limited independent explanatory power. Genomic prediction declined when genetic backgrounds were absent from training, and when leading predictive features differed among backgrounds. We also found that models trained on a curated list of mutations and variant effect predictors performed well when classifying drug-susceptible strains, but the drug-resistance trait was predicted with lower accuracy. These findings support the potential of genome-based resistance prediction while highlighting the need for broader population sampling, functional validation of candidate variants and expanded resistance catalogues to improve prediction across genetic backgrounds.
ER  -